logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Azole Antifungal class drugs

    FiltersReset Filters
    7 results

    • clotrimazole topical solution usp, 1%

      (Clotrimazole Topical Solution USP, 1%)
      TruPharma LLC
      Usage: Clotrimazole topical solution is indicated for treating candidiasis caused by *Candida albicans* and tinea versicolor due to *Malassezia furfur*. The nonprescription formulation treats tinea pedis, tinea cruris, and tinea corporis caused by various fungi, including *Trichophyton* and *Microsporum* species.

    • exelderm

      (Sulconazole Nitrate)
      Journey Medical Corporation
      Usage: EXELDERM (sulconazole nitrate, USP) CREAM, 1.0% is indicated for treating tinea pedis (athlete's foot), tinea cruris, tinea corporis, and tinea versicolor, caused by specific fungi including Trichophyton rubrum and Microsporum canis, among others. Efficacy for some organisms was studied in limited cases.

    • fluconazole

      (Fluconazole)
      BluePoint Laboratories
      Usage: Fluconazole tablets are indicated for treating vaginal candidiasis, oropharyngeal and esophageal candidiasis, cryptococcal meningitis, and for prophylaxis against candidiasis in patients undergoing bone marrow transplantation. Laboratory studies should precede therapy, but treatment may begin before results are available.

    • jublia

      (efinaconazole)
      Bausch Health US LLC
      Usage: JUBLIA (efinaconazole) topical solution, 10% is indicated for the topical treatment of onychomycosis of the toenails caused by Trichophyton rubrum and Trichophyton mentagrophytes.

    • luzu

      (LULICONAZOLE)
      Bausch Health US, LLC
      Usage: LUZU (luliconazole) Cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by *Trichophyton rubrum* and *Epidermophyton floccosum*.

    • recorlev

      (Levoketoconazole)
      Xeris Pharmaceuticals, Inc.
      Usage: RECORLEV is indicated for treating endogenous hypercortisolemia in adults with Cushing’s syndrome when surgery is not an option or has not been curative. It is not approved for fungal infections, and its safety and effectiveness for such uses are not established.

    • vivjoa

      (oteseconazole)
      Mycovia Pharmaceuticals, Inc.
      Usage: VIVJOA is indicated for reducing the recurrence of vulvovaginal candidiasis in females with a history of the condition who are not of reproductive potential. Adjust antifungal therapy based on fungal culture results if obtained prior to treatment.